Greencamp
AUGUST 16, 2018
Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.
The Cannigma
JANUARY 13, 2023
Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. 4 A 2004 study found that the endocannabinoid anandamide can inhibit trigeminal neurons, which suggests a way in which endocannabinoids may be able to prevent migraines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
NOVEMBER 24, 2021
It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. Both lines of thought have to contend with one significant fact: the illegal market remains the dominant mode of cannabis production and consumption.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. September 2004. 30 (2): 187–96.(1998).
Expert insights. Personalized for you.
94 
Let's personalize your content